Diethylamine

Diethylamine

SCHEMBL6640415

CCNCC.Cc1ccnc(C=O)c1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ UHRF1 Q96T88 1/20 0.41
▸ CCR1 P32246 1/20 0.41
▸ CCR5 P51681 1/20 0.41
▸ CCR8 P51685 1/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ LMNA P02545 3/20 0.40
▸ KDM4E B2RXH2 5/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ NOS2 P35228 2/20 0.38
▸ NOS3 P29474 1/20 0.38
▸ NOS1 P29475 1/20 0.38
▸ HPGD P15428 3/20 0.37
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ PKM P14618 1/20 0.35
▸ FDPS P14324 1/20 0.35
▸ CYP2A6 P11509 1/20 0.34
▸ POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29875378 0.89 — —
SCHEMBL457223 0.89 — —
SCHEMBL1707627 0.75 UHRF1 (0.48) UHRF1CCR1CCR5CCR8ALDH1A1
SCHEMBL25375499 0.74 KDM4A (0.51) ALDH1A1KMT2ASMN1; SMN2KDM4EMEN1
SCHEMBL7089255 0.73 NOS2 (0.36) ALDH1A1KMT2ALMNAKDM4EMEN1
SCHEMBL6642166 0.72 NOS3 (0.52) ALDH1A1KMT2ASMN1; SMN2LMNAKDM4E
Diethylamine SCHEMBL6639815 0.71 KMT2A (0.44) UHRF1CCR1CCR5CCR8ALDH1A1
SCHEMBL2259096 0.70 KDM1A (0.47) UHRF1CCR1CCR5CCR8ALDH1A1
SCHEMBL20412648 0.70 CCR1 (0.59) UHRF1CCR1CCR5CCR8ALDH1A1
SCHEMBL1707282 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0824524-B1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE UPJOHN CO (US) 2004-09-08 — — EP disclosed
EP-1449835-A2 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds PHARMACIA & UPJOHN COMPANY (US) 2004-08-25 — — EP disclosed
US-6043248-A VIRICIDES FOR TREATING AN INDIVIDUAL INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS PHARMACIA & UPJOHN COMPANY (US) 2000-03-28 — — US disclosed
EP-0824524-A1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE PHARMACIA & UPJOHN COMPANY (US) 1998-02-25 — — EP disclosed
WO-1996035678-A1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE PHARMACIA & UPJOHN COMPANY (US) 1996-11-14 — — WO disclosed
Send feedback